2 completed, 1 active not recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
Follow Brain and Nervous System: new trials by email Literature Review of Brain and Nervous System trials Research Report on Brain and Nervous System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme B7-H3CART - Brain and Nervous System | Phase 1 | Active not recruiting | Stanford University | 18 | 2022-07-12 | 2026-11-13 |
| Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma Nivolumab - Brain and Nervous System, Eye and Orbit | Phase 1 | Completed | Wake Forest University Health Sciences | 14 | 2020-03-31 | 2025-12-30 |
| A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors Irinotecan, Thalidomide - Brain and Nervous System, Cancer | Phase 1 | Completed | University of New Mexico | 10 | 2000-03-01 | 2010-01-07 |
Neurologic Manifestations (3) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Lymphoma (1) · Neoplasms (1)
Nervous System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Brain Diseases (1) · Central Nervous System Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Nervous System Neoplasms (1)
Irinotecan (1) · Nivolumab (1) · Thalidomide (1)
Stanford University (1) · University of New Mexico (1) · Wake Forest University Health Sciences (1)
United States (3)
Dennie Jones, MD (1) · Reena Thomas, MD, PhD (1) · Steven Park, MD (1)